Edecesertib

N/A

Report date: 2026/02/18 20:02:09
NME

Base Information

Drug NameEdecesertib
Drug Alias NameGS-5718GS5718
ClassificationSmall molecules
Mechanisms of ActionInterleukin-1 receptor-associated kinase 1 antagonists
TargetsInterleukin-1 receptor-associated kinase 1
Therapy Area/IndicationsLupus Erythematosus, CutaneousArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermanySpain
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGilead Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGilead Sciences Inc
Active IndicationsN/A
Inactive IndicationsLupus Erythematosus, CutaneousArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A